Skip to main content

Table 2 Univariate analysis of overall mortality of 100 patients infected by S. maltophilia

From: Infection and colonization by Stenotrophomonas maltophilia: antimicrobial susceptibility and clinical background of strains isolated at a tertiary care centre in Hungary

 

Died (n = 45)

Survived (n = 55)

p value

 

No (%)

No (%)

 

Age in years, median (range)

67 (0–88)

62 (0–88)

-

Gender, male

23 (51.1)

35 (63.6)

0.29

Hematological malignancy

3 (6.6)

3 (5.4)

0.31

Advanced cancer

10 (22.2)

8 (14.5)

0.54

Diabetes mellitus

16 (35.5)

16 (29.1)

0.22

Corticosteroid use

4 (8.8)

8 (14.5)

0.31

Chemotherapy

4 (8.8)

11 (20)

0.2

Neutropenia (<0.5 G/L)

5 (11.1)

2 (3.6)

0.24

Post-transplantation stage

0

5 (9.1)

-

Chronic heart disease

15 (33.3)

18 (32.7)

0.88

Chronic kidney disease, hemodialysis

10 (22.2)

5 (9.1)

0.12

Chronic lung disease

13 (28.8)

14 (25.4)

0.87

Chronic liver disease

5 (11.1)

7 (12.7)

0.95

Hypertension

30 (66.6)

25 (45.4)

0.05

Admission to intensive care unit

43 (95.5)

32 (58.2)

0.00005

Need for vasopressors

26 (57.7)

8 (14.5)

0.00001

Central venous catheter

42 (93.3)

29 (52.7)

0.00001

Need for mechanical ventilation

41 (91.1)

28 (50.9)

0.00004

Severe sepsis, septic shock, multiorgan failure

23 (51.1)

5 (9.1)

0.00001

Non-S. maltophilia bloodstream infection

15 (33.3)

9 (16.3)

0.08

S. maltophilia bloodstream infection

12 (26.6)

13 (23.6)

0.9

Recent surgery

18 (40)

12 (21.8)

0.08

Polymicrobial infection

35 (77.7)

33 (60)

0.09

  1. p-value < 0.05 was considered to be significant.
  2. Data in boldface are significant.